🔎 Trials Near Me

Domov › Choroby pľúc › Massachusetts

Klinické štúdie Choroby pľúc v štáte Massachusetts

15 štúdií pre Choroby pľúc hľadá účastníkov v zariadeniach v štáte Massachusetts.

Mestá v štáte Massachusetts

Oficiálny text štúdie (anglicky)

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

  • Dana-Farber Cancer Institute, Boston
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT06765109

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

  • Brigham and Women's Hospital, Boston
  • Lucida Clinical Trials, New Bedford
  • University of Massachusetts Chan Medical School, Worcester
Prebieha náborFáza 3
Vek 12 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06679140

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

  • Brigham and Women's Hospital, Boston
  • Clinical Trials Center, Boston
  • Clinical Trials Hub, Boston
  • a 1 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07013474

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

  • Brigham and Women's Hospital, Boston
Prebieha náborFáza 2
Vek 40 až 75 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07759245

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • Dana Farber Cancer Institute, Boston
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT06128551

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Boston Medical Center, Boston
  • Lahey Hospital & Medical Center, Burlington
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 8. 9. 2026 · NCT06119581

Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

  • Infinity Medical Research, North Dartmouth
Prebieha náborFáza 3
Vek 40 a viac · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT07284602

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

  • Clinical Research Site, Boston
Prebieha náborFáza 2
Vek 18 až 85 · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT07333183

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

  • Beth Israel Deaconess Medical Center, Boston
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 9. 2026 · NCT05967689

BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)

  • Dana-Farber Cancer Institute, Boston
  • Boston Children's Hospital, Boston
  • Brigham and Women's Hospital, Boston
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 10. 6. 2026 · NCT05922761

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  • Massachusetts General Hospital,, Boston
Prebieha náborFáza 1/2
Vek 12 a viac · Všetky pohlavia · Aktualizované 27. 5. 2026 · NCT03093116

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

  • VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 19. 2. 2026 · NCT02984761

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

  • Dana-Farber Cancer Institute, Boston
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 12. 2025 · NCT06619561

Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System

  • Brigham and Women's Hospital, Boston
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 9. 2025 · NCT04555161

Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.